For further details see:
J&J's daratumumab extends survival in first-line multiple myelomaFor further details see:
J&J's daratumumab extends survival in first-line multiple myelomaMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Johnson & Johnson (NYSE: JNJ) will participate in the 2024 Wells Fargo Healthcare Conference on Thursday, September 5 th , at the Encore Boston Harbor, Evertte, MA. Tim Schmid, Executive Vice President, WorldWide Chairman, MedTech will represent the Company in a session scheduled at 11:00...
2024-07-27 06:35:00 ET One of the biggest risks facing Johnson & Johnson (NYSE: JNJ) in recent years has been its exposure to talc lawsuits. The uncertainty around that issue is a key reason why shares of Johnson & Johnson have declined by 9% in the past three years, with ...
Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 22 nd Annual Global Healthcare Conference on Wednesday, September 4 th , held at the New York Marriott Marquis, New York, NY. Joaquin Duato, Chairman and Chief Executive Officer and John Reed, Executive Vice Presiden...